Latest news

• EMA starts contraceptive safety probe

  France's move was prompted by reports of blood clots (venous thromboembolism) with the more recently-introduced oral contraceptive products, which incorporate newer progestins such as drospirenone, gestodene and desogestrel, rather ... Leading third- and

• FDA panel backs Bayer's Yaz/Yasmin; warns over blood clots

  Yaz and related drospirenone-based medicines Yasmin and Yasminelle is a big-earning franchise for Bayer. ... Other brands which contain drospirenone include Beyaz (Bayer), Ocella (Barr), Loryna (Sandoz), Gianvi (Teva), Safyral (Bayer), Syeda (Sandoz) and

• Major increase for Bayer's Q2 profit

  Weakening sales in North America and Europe for Bayer's pharmaceutical products, due in part to generic competition for oral contraceptive Yaz (drospirenone/ethinyl estradiol), were offset by growth in emerging

• FDA warns about birth control pills

  The US Food and Drug Administration has issued a safety review following links between birth control pills containing drospirenone and an increase in blood clots. ... Drospirenone is a type of female sex hormone called a progestin, which works by

• Study ranks top pharma websites

  Bayer's oral contraceptive Yaz (drospirenone and ethinyl estradiol), Pfizer's fibromyalgia drug Lyrica (pregabalin), Merck's contraceptive vaginal ring NuvaRing (progestin and estrogen), AstraZeneca's asthma treatment Symbicort (budesonide and